Elizabeth A. Williamson

4.7k total citations · 2 hit papers
71 papers, 3.8k citations indexed

About

Elizabeth A. Williamson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Elizabeth A. Williamson has authored 71 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Elizabeth A. Williamson's work include DNA Repair Mechanisms (37 papers), CRISPR and Genetic Engineering (12 papers) and Epigenetics and DNA Methylation (11 papers). Elizabeth A. Williamson is often cited by papers focused on DNA Repair Mechanisms (37 papers), CRISPR and Genetic Engineering (12 papers) and Epigenetics and DNA Methylation (11 papers). Elizabeth A. Williamson collaborates with scholars based in United States, United Kingdom and Japan. Elizabeth A. Williamson's co-authors include H. Phillip Koeffler, Robert Hromas, Hiroya Asou, Jonathan Said, Kozo Koshizuka, Jac A. Nickoloff, Suk‐Hee Lee, Elena Elstner, David Heber and Carsten Müller‐Tidow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Elizabeth A. Williamson

70 papers receiving 3.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1998 719 citations Elena Elstner, Elizabeth A. Williamson et al. profile →
Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

1998 534 citations Elizabeth A. Williamson, Jonathan Said et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth A. Williamson United States	33	3.0k	999	772	418	384	71	3.8k
Emma Shtivelman United States	33	2.4k 0.8×	602 0.6×	931 1.2×	279 0.7×	191 0.5×	42	4.2k
Jens Hoffmann Germany	26	1.0k 0.3×	520 0.5×	950 1.2×	310 0.7×	143 0.4×	117	2.4k
Xiangdong Le United States	32	2.4k 0.8×	1.1k 1.1×	1.0k 1.3×	302 0.7×	106 0.3×	39	3.5k
Richard Kendall United States	24	1.8k 0.6×	476 0.5×	837 1.1×	153 0.4×	124 0.3×	43	3.0k
Spyro Mousses United States	29	2.4k 0.8×	744 0.7×	816 1.1×	538 1.3×	57 0.1×	65	3.3k
Andrew H. Sims United Kingdom	39	3.0k 1.0×	1.6k 1.6×	1.8k 2.3×	432 1.0×	91 0.2×	127	4.9k
Yaguang Xi United States	34	3.8k 1.3×	3.0k 3.0×	808 1.0×	146 0.3×	124 0.3×	78	4.9k
Álvaro J. Obaya Spain	26	2.1k 0.7×	723 0.7×	1.1k 1.5×	314 0.8×	66 0.2×	49	3.3k
Dimpy Koul United States	33	2.6k 0.8×	892 0.9×	877 1.1×	167 0.4×	128 0.3×	63	3.7k
Sophie Vacher France	39	2.6k 0.9×	1.5k 1.5×	1.5k 1.9×	448 1.1×	89 0.2×	142	4.5k

Countries citing papers authored by Elizabeth A. Williamson

Since Specialization

Citations

This map shows the geographic impact of Elizabeth A. Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Williamson more than expected).

Fields of papers citing papers by Elizabeth A. Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Williamson. The network helps show where Elizabeth A. Williamson may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Williamson. A scholar is included among the top collaborators of Elizabeth A. Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Williamson. Elizabeth A. Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jaiswal, Aruna S., Orlando D. Schärer, Neelam Sharma, et al.. (2023). EEPD1 promotes repair of oxidatively-stressed replication forks. NAR Cancer. 5(1). zcac044–zcac044. 8 indexed citations

Jaiswal, Aruna S., Arijit Dutta, Gayathri Srinivasan, et al.. (2023). TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. Nucleic Acids Research. 51(22). 12224–12241. 10 indexed citations

Nickoloff, Jac A., Aruna S. Jaiswal, Neelam Sharma, et al.. (2023). Cellular Responses to Widespread DNA Replication Stress. International Journal of Molecular Sciences. 24(23). 16903–16903. 15 indexed citations

Jaiswal, Aruna S., et al.. (2023). In Vitro Reconstitutive Base Excision Repair (BER) Assay. Methods in molecular biology. 2701. 91–112. 1 indexed citations

Hromas, Robert, Gayathri Srinivasan, Ming Yang, et al.. (2022). BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1. iScience. 25(12). 105626–105626. 7 indexed citations

Thummuri, Dinesh, Sajid Khan, Patrick W. Underwood, et al.. (2021). Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216. Molecular Cancer Therapeutics. 21(1). 184–192. 51 indexed citations

Capitano, Maegan L., Aruna S. Jaiswal, Hal E. Broxmeyer, et al.. (2021). A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease. PLoS ONE. 16(7). e0252805–e0252805. 4 indexed citations

Shao, Lijian, Jianhui Chang, Wei Feng, et al.. (2018). The Wave2 scaffold Hem-1 is required for transition of fetal liver hematopoiesis to bone marrow. Nature Communications. 9(1). 2377–2377. 12 indexed citations

Hromas, Robert, Hyun‐Suk Kim, Gurjit Sidhu, et al.. (2017). The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells. Breast Cancer Research. 19(1). 122–122. 33 indexed citations

10.

Nickoloff, Jac A., Dennie V. Jones, Suk‐Hee Lee, Elizabeth A. Williamson, & Robert Hromas. (2017). Drugging the Cancers Addicted to DNA Repair. PMC. 3 indexed citations

11.

Nickoloff, Jac A., Dennie V. Jones, Suk‐Hee Lee, Elizabeth A. Williamson, & Robert Hromas. (2017). Drugging the Cancers Addicted to DNA Repair. JNCI Journal of the National Cancer Institute. 109(11). 114 indexed citations

12.

Williamson, Elizabeth A., Leah A. Damiani, Andrei Leitão, et al.. (2012). Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy. Cancer Research. 72(23). 6200–6208. 30 indexed citations

13.

Williamson, Elizabeth A., Justin Wray, Pranshu Bansal, & Robert Hromas. (2012). Overview for the Histone Codes for DNA Repair. Progress in molecular biology and translational science. 110. 207–227. 41 indexed citations

14.

Hromas, Robert, et al.. (2012). Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart. Oncogene. 31(38). 4245–4254. 32 indexed citations

15.

Williamson, Elizabeth A., et al.. (2011). Panduan Survei dan Pemantauan Populasi Kera Besar. IUCN eBooks. 2 indexed citations

16.

Beck, Brian D., et al.. (2011). Biochemical Characterization of Metnase’s Endonuclease Activity and Its Role in NHEJ Repair. Biochemistry. 50(20). 4360–4370. 41 indexed citations

17.

Kong, Kimi, et al.. (2009). Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4. Blood. 114(1). 60–63. 7 indexed citations

18.

Elstner, Elena, Elizabeth A. Williamson, C. Zang, et al.. (2002). Novel Therapeutic Approach: Ligands for PPARγ and Retinoid Receptors Induce Apoptosis in bcl-2-positive Human Breast Cancer Cells. Breast Cancer Research and Treatment. 74(2). 155–165. 74 indexed citations

19.

Williamson, Elizabeth A., Farnaz Dadmanesh, & H. Phillip Koeffler. (2002). BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1. Oncogene. 21(20). 3199–3206. 50 indexed citations

20.

Elstner, Elena, et al.. (2000). Novel therapeutic approach: organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo. British Journal of Cancer. 82(2). 452–458. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact